Mayo Clinic Radio: Cardiac Regeneration/Stop-Smoking Drug/Juicing
On this week’s Mayo Clinic Radio, fixing a broken heart. Cardiac regeneration uses the body’s own stem cells to repair damage done by heart disease. Mayo Clinic cardiologist Dr. Atta Behfar explains. Also on the program, nicotine dependency expert Dr. Richard Hurt discusses results of a new study about the stop-smoking drug varenicline (Chantix). And Mayo [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 16, 2015 Category: Databases & Libraries Source Type: news
Varenicline as a cause of suicidal outcomes - Hughes JR.
This article reviews post-marketing analyses, case reports, clinical trials, uncontrolled observational studies, controlled observational studies, ... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - January 23, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news
Blood test may tell you the 'best' way to quit smoking
Conclusion
This is a well-conducted randomised controlled trial, which found that use of the nicotine-metabolite ratio (NMR) may be helpful in indicating which stop smoking treatment may be best for different people. For those with a normal NMR, varenicline was more effective than a nicotine patch. For slower metabolisers, there was no significant difference in the effectiveness of the two treatments, but they tended to get more side effects with varenicline.
The study benefits from its large size, double-blind design and high follow-up rates.
However, there are still questions to be answered. For example, the difference ...
Source: NHS News Feed - January 12, 2015 Category: Consumer Health News Tags: Heart/lungs Medication Medical practice Cancer Source Type: news
Varenicline May Affect Normal and Slow Metabolizers of Nicotine Differently (FREE)
By Kelly Young
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
Varenicline is associated with higher cessation rates in smokers who metabolize nicotine normally but with more side effects in slow metabolizers, according to a Lancet … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 12, 2015 Category: Primary Care Source Type: news
Nicotine metabolism rates may impact success of smoking cessation treatments
A randomized clinical trial of smokers trying to quit found that the effectiveness of particular smoking cessation therapies might relate to how quickly their body metabolizes nicotine. The study compared success rates of the nicotine patch versus the prescription medication varenicline.
Among... (Source: NIDA News)
Source: NIDA News - January 12, 2015 Category: Addiction Tags: Health and Medical Professionals, Researchers, Tobacco, Treatment Research Source Type: news
Nicotine metabolism rates may impact success of smoking cessation treatments
A randomized clinical trial of smokers trying to quit found that the effectiveness of particular smoking cessation therapies might relate to how quickly their body metabolizes nicotine. The study compared success rates of the nicotine patch versus the prescription medication varenicline.
Among... (Source: NIDA News)
Source: NIDA News - January 12, 2015 Category: Addiction Tags: Health and Medical Professionals, Researchers, Tobacco, Treatment Research Source Type: news
Increasing Varenicline Dose Unlikely to Help in NonrespondersIncreasing Varenicline Dose Unlikely to Help in Nonresponders
Don't bother raising the dose of varenicline (Chantix) when smokers don't respond to the standard dose; it won't help, according to a new study. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 30, 2014 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Pharmaceutical Aids Not Found to Be Helpful for Smoking Cessation
No evidence that varenicline, bupropion, or nicotine replacement increase probability of abstinence (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 11, 2014 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news
Smoking Cessation Drug Tied to Increased Cardiovascular Risk
Varenicline associated with increased incidence of CV events in first 12 weeks after receipt of drug (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - November 11, 2014 Category: Psychiatry Tags: Cardiology, Family Medicine, Gynecology, Internal Medicine, Neurology, Nursing, Pharmacy, Psychiatry, Pulmonology, Journal, Source Type: news
Varenicline Linked to Reduction in Heavy Drinking in Men
Also associated with smoking abstinence in overall sample of participants (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - November 11, 2014 Category: Psychiatry Tags: Family Medicine, Geriatrics, Internal Medicine, Nursing, Pharmacy, Psychiatry, Pulmonology, Journal, Source Type: news
Varenicline poisoning for a suicidal purpose - Sørup FH, Neumann AB, Holst H.
We report a history of a 45-year-old woman who ingested 40-50 mg varenicline. She... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - October 31, 2014 Category: Global & Universal Tags: Poisoning Source Type: news
FDA Advisers Vote to Keep Black-Box Warning on Chantix (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD An FDA advisory panel voted late last week to keep the black-box warning on the smoking cessation drug varenicline … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 20, 2014 Category: Primary Care Source Type: news
FDA panel supports retaining Chantix boxed warning for now
Read the full story on MD Consult:
FDA panel supports retaining Chantix boxed warning for now (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - October 20, 2014 Category: Journals (General) Source Type: news
FDA Advisers Vote to Keep Black-Box Warning on Chantix (FREE)
By Amy Orciari Herman
Edited by Susan Sadoughi, MD
An FDA advisory panel voted late last week to keep the black-box warning on the smoking cessation drug varenicline … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 20, 2014 Category: Primary Care Source Type: news
D.C. Week: Of Travel Bans and Chantix
(MedPage Today) -- Recess notwithstanding, Congress had advice on Ebola. (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - October 18, 2014 Category: Respiratory Medicine Source Type: news
